KLI
Login
OAK 국가리포지터리
검색
커뮤니티
제목
저자
키워드
발행일
Ulsan Univ. Repository
Browsing by 키워드 : Nivolumab
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
가
나
다
라
마
바
사
아
자
차
카
타
파
하
All
가
나
다
라
마
바
사
아
자
차
카
타
파
하
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
또는 첫 단어:
정렬 기준:
제목
발행일
제출일
정렬:
오름차순
내림차순
결과 수
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
저자 수
All
1
3
5
10
15
20
25
30
35
40
45
50
전체 결과 12건 중 1-12 번을 표시중입니다.
1
Article
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data
강윤구
;
유민희
;
Do?Youn Oh
;
et al
2020
2
Article
Clinical activity of nivolumab in combination with eribulin in HER2-negative metastatic breast cancer: A phase IB/II study (KCSG BR18-16)
Se Hyun Kim
;
Seock-Ah Im
;
Koung Jin Suh
;
et al
2023
3
Article
Clinical outcomes of immune checkpoint inhibitors in unresectable or metastatic combined hepatocellular-cholangiocarcinoma
Yoon Jung Jang
;
Eo Jin Kim
;
Hyung-Don Kim
;
et al
2023
4
Article
Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma
Seung Hyuck Jeon
;
Yong Joon Lee
;
Hyung-Don Kim
;
et al
2023
5
Article
Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 study
Yoon-Koo Kang
;
Satoshi Morita
;
Taroh Satoh
;
et al
2022
6
Article
Insertion-deletion rate is a qualitative aspect of the tumor mutation burden associated with the clinical outcomes of gastric cancer patients treated with nivolumab
Hyung-Don Kim
;
Min-Hee Ryu
;
Young Soo Park
;
et al
2022
7
Article
Nivolumab in previously treated advanced gastric cancer (ATTRACTION-2): 3-year update and outcome of treatment beyond progression with nivolumab
· Li?Tzong Chen
;
· Li?Yuan Bai1
;
· Taihei Nishiyama
;
et al
2021
8
Article
Predictive biomarkers for the efficacy of nivolumab as ≥ 3rd-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial
Jwa Hoon Kim
;
Min-Hee Ryu
;
Young Soo Park
;
et al
2022
9
Article
Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
Jwa Hoon Kim
;
Bokyung Ahn
;
Seung-Mo Hong
;
et al
2022
10
Article
Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors
Talal El Zarif
;
Amin H Nassar
;
Gregory R Pond
;
et al
2023
11
Article
Safety of First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC: A Pooled Analysis of CheckMate 227, CheckMate 568, and CheckMate 817
Luis G Paz-Ares
;
Tudor-Eliade Ciuleanu
;
Adam Pluzanski
;
et al
2023
12
Article
Systemic and Intracranial Outcomes With First-Line Nivolumab Plus Ipilimumab in Patients With Metastatic NSCLC and Baseline Brain Metastases From CheckMate 227 Part 1
Martin Reck
;
Tudor-Eliade Ciuleanu
;
Jong-Seok Lee
;
et al
2023
1
Anonymous
Login
커뮤니티
제목
저자
키워드
발행일
Guide